Biotech and Big Pharma are under pressure, and the old rules no longer apply.
Download our infographic to gain an exclusive first look at the forces driving pharma industry change.
From biotech’s lean transformation and China’s R&D surge, to direct-to-consumer sales and pricing reform, we’ve distilled the most disruptive trends into a compelling visual snapshot.
This is your early access to the insights ahead of the full Pharma v Biotech: New Rules? report release.
The infographic highlights:
- Pharma goes direct-to-customer, biotechs push into commercialization, and new investors enter the scene
- Rising R&D costs and pricing pressures are forcing tough choices for Big Pharma
- China’s biopharma sector is rapidly stepping up as a challenger to Western dominance
Whatever your role across life sciences, download now to get ahead of the curve before the full story drops.
